News Flash: Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. Achieves Major Milestone with Approval of Self-Developed Apalutamide API

Chenghui Shuangda 5

Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. proudly announces that its self-developed Active Pharmaceutical Ingredient (API), Apalutamide (Registration No.: Y20240001176), has successful...

Shandong Chenghui Pharmaceuticals: Warmth of the Season, Prosperous Year of the Horse – Spring Festival Benefits Convey Gratitude for Every Dedication

Chenghui Shuangda 19

To All Colleagues and Partners Time surges forward, and our journey of striving never pauses. As we bid farewell to the old and welcome the new, Shandong Chenghui Pharmace...

New Year Greeting from Shandong Chenghui Pharma

Chenghui Shuangda 40

As the year 2026 approaches, we at Shandong Chenghui Pharmaceutical extend our warmest wishes to our global partners and clients. May the New Year bring you prosperity, good health, and continued ...

Global Recognition: Prilocaine CEP Certified by EDQM

Chenghui Shuangda 134

On December 19, 2025, our company reached a pivotal milestone in international pharmaceutical development, as the European Pharmacopoeia Suitability Certificate (CEP) for the active pharmaceutical in...

Corporate News: Successful Approval of CEP Certificate for Lidocaine Hydrochloride API by EDQM

Chenghui Shuangda 148

On November 10, 2025, our company successfully obtained approval for the European CEP registration of our active pharmaceutical ingredient (API), Lidocaine Hydrochloride. We have received the Certific...

Shandong Chenhui Pharmaceutical Group Shines at CPHI Worldwide Europe 2025

Chenghui Shuangda 106

From October 28th to 30th, 2025, Shandong Chenhui Pharmaceutical Group made a remarkable appearance at the CPHI Worldwide Europe exhibition in Frankfurt, Germany. This premier industry event brought ...

Shandong Chenghui Pharma Group Invites You to Visit Booth A5011 at Pharmtech & Ingredients 2025

Chenghui Shuangda 85

Achinery Exhibition (Pharmtech & Ingredients) will be held at the Crocus Expo IEC in Moscow. Shandong Chenghui Pharmaceutical Group will showcase its core products and technical solutions ...

Join Shandong Chenghui Pharmaceutical Group at API China 2025 – Booth 5M22, Hall 5N

Chenghui Shuangda 60

From November 12th to 14th, 2025, the 93rd China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Trade Fair (API China) will grandly open at the Chongqing International E...

EDQM Certifies Lidocaine CEP: A Milestone for International Expansion

Chenghui Shuangda 132

‌On October 9, 2025, our company's active pharmaceutical ingredient (API) ‌Lidocaine‌ received approval for its ‌European CEP (Certificate of Suitability to the European Pharmacopoeia)‌ registration ...

CPHI Europe 2025 Preview: Connect Globally at Chenghui Shuangda’s Booth 12.0F108!

Chenghui Shuangda 96

Mark your calendars! The premier gathering for the global pharmaceutical industry—CPHI Worldwide Europe 2025—will take place from October 28 to 30, 2025 at the iconic Messe Frankfurt exhibition c...